Zobrazeno 1 - 10
of 270
pro vyhledávání: '"Charles Chazot"'
Autor:
Sebastian Mussnig, MD, Janosch Niknam, MD, Christoph Matthias, Susanne Widmer, Dilara Gülmez, Simon Krenn, MD, Matthias Lorenz, MD, Charles Chazot, PhD, Peter Wabel, PhD, Daniel Schneditz, PhD, Manfred Hecking, PhD
Publikováno v:
Kidney Medicine, Vol 6, Iss 7, Pp 100837- (2024)
Externí odkaz:
https://doaj.org/article/30615847fdbc4177aea787875621d19f
Autor:
Charles Chazot, Guillaume Jean
Publikováno v:
Bulletin de la Dialyse à Domicile, Vol 5, Iss 3, Pp 223-232 (2022)
L’hémodialyse (HD) Longue Nocturne (HDLN) intermittente permet de combiner dialyse et sommeil. Ses avantages cliniques sont une vitesse d’ultrafiltration réduite, un meilleur contrôle de la volémie avec amélioration de la tolérance des séa
Externí odkaz:
https://doaj.org/article/a39baa240c6844e3aa981a0796ae39a0
Autor:
Hedia Hebibi, David Attaf, Laure Cornillac, Jejiga Achiche, Fatia El Boundri, Patrick Francais, Charles Chazot, Bernard Canaud
Publikováno v:
Kidney International Reports, Vol 6, Iss 2, Pp 351-356 (2021)
Introduction: Administration of low-molecular-weight heparins (LMWHs) is necessary for preventing extracorporeal circuit thrombosis during hemodialysis. A substantial amount of LMWH is removed with online hemodiafiltration (OL-HDF) when administered
Externí odkaz:
https://doaj.org/article/2369425964cc44618fccda11211c7f5b
Autor:
Rosa Ramos, Charles Chazot, Anibal Ferreira, Attilio Di Benedetto, Konstantin Gurevich, Astrid Feuersenger, Melanie Wolf, Hans-Jürgen Arens, Sebastian Walpen, Stefano Stuard
Publikováno v:
BMC Nephrology, Vol 21, Iss 1, Pp 1-12 (2020)
Abstract Background The iron-based phosphate binder (PB), sucroferric oxyhydroxide (SFOH), demonstrated its effectiveness for lowering serum phosphate levels, with low daily pill burden, in clinical trials of dialysis patients with hyperphosphatemia.
Externí odkaz:
https://doaj.org/article/1ad472bf98674f95a0199c5a754f5eeb
Autor:
Ziad A. Massy, Jean Ferrières, Eric Bruckert, Céline Lange, Sophie Liabeuf, Maja Velkovski-Rouyer, Bénédicte Stengel, Carole Ayav, Christian Combe, Denis Fouque, Luc Frimat, Yves-Edouard Herpe, Maurice Laville, Ziad Massy, Karine Legrand, Marie Metzger, Elodie Speyer, Bruno Moulin, Gaétan Lebrun, Éric Magnant, Gabriel Choukroun, Jean Philippe Bourdenx, Marie Essig, Raymond Azar, Mustafa Smati, Mohamed Jamali, Alexandre Klein, Michel Delahousse, Séverine Martin, Eric Thervet, Xavier Belenfant, Pablo Urena, Carlos Vela, Dominique Chauveau, Viktor Panescu, François Glowacki, Maxime Hoffmann, Maryvonne Hourmant, Dominique Besnier, Angelo Testa, Philippe Zaoui, Charles Chazot, Laurent Juillard, Stéphane Burtey, Adrien Keller, Nassim Kamar
Publikováno v:
Kidney International Reports, Vol 4, Iss 11, Pp 1546-1554 (2019)
Introduction: We describe the characteristics of patients with moderate/advanced chronic kidney disease (CKD) according to receipt of lipid-lowering therapy (LLT), and whether they achieved low-density lipoprotein cholesterol (LDL-C) targets for high
Externí odkaz:
https://doaj.org/article/2e2d670b48f24d0da27d45f04c41f401
Autor:
Hadia Hebibi, Magali Ciroldi, Laure Cornillac, Samah Saibi, Fatia El Boundri, Charles Chazot, David Attaf
Publikováno v:
Bulletin de la Dialyse à Domicile, Vol 4, Iss 2 (2021)
Abstract: Between 2015 and 2017 there was a 40% increase in daily hemodialysis, according to the REIN database. This increase concerns 1% of patients and the private sector remains under-represented. Our retrospective study aims to describe the clini
Externí odkaz:
https://doaj.org/article/fbbd32004f354e7a8df1447290758dfb
Autor:
Charles Chazot, Hafsah Hachad, Pierre Filipozzi, Cécile Legallais, Perrine Jullien, Fabrice Huré, Karim Dardim, Catherine Lasseur, Hubert Metayer, Didier Aguilera, Agnès Caillette-Beaudoin, Christophe Mariat, Maryvonne Hourmant
Publikováno v:
Néphrologie & Thérapeutique. 19:23-33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e521b4a1a91259c9dce035e9a3176aaf
https://doi.org/10.1684/ndt.2023.1
https://doi.org/10.1684/ndt.2023.1
Autor:
Manfred Hecking, Magdalena Madero, Friedrich K. Port, Daniel Schneditz, Peter Wabel, Charles Chazot
Publikováno v:
Kidney International. 103:2-5
Every hemodialysis session starts with the question of how much fluid should be removed, which can currently not be answered precisely. Herein, we first revisit the "probing-dry-weight" concept, using the historical example of Tassin/France (practici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e023114d93f4d088f9a988d7983590fb
https://doi.org/10.1016/j.kint.2022.09.021
https://doi.org/10.1016/j.kint.2022.09.021
Autor:
Guillaume Jean, Jean-Christophe Lifante, Éric Bresson, Jean-Marie Ramackers, Guillaume Chazot, Charles Chazot
Publikováno v:
Néphrologie & Thérapeutique. 18:616-626
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fd2760466cd4e1ebaeb3c8dd7a7b996
https://doi.org/10.1016/j.nephro.2022.07.400
https://doi.org/10.1016/j.nephro.2022.07.400
Autor:
Charles Chazot, Guillaume Jean
Publikováno v:
Bulletin de la Dialyse à Domicile. 5:223-232
L’hémodialyse (HD) Longue Nocturne (HDLN) intermittente permet de combiner dialyse et sommeil. Ses avantages cliniques sont une vitesse d’ultrafiltration réduite, un meilleur contrôle de la volémie avec amélioration de la tolérance des séa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e6f5fa3d6b8464e4548072d75a48b3b
https://doi.org/10.25796/bdd.v5i3.67683
https://doi.org/10.25796/bdd.v5i3.67683